Eton Pharmaceuticals Q3 EPS $(0.28) Misses $(0.25) Estimate

Eton Pharmaceuticals (NASDAQ:ETON) reported quarterly losses of $(0.28) per share which missed the analyst consensus estimate of $(0.25) by 12 percent. This is a 56.92 percent increase over losses of $(0.65) per share

Benzinga · 11/14/2019 21:08

Eton Pharmaceuticals (NASDAQ:ETON) reported quarterly losses of $(0.28) per share which missed the analyst consensus estimate of $(0.25) by 12 percent. This is a 56.92 percent increase over losses of $(0.65) per share from the same period last year.